UroGen Pharma Ltd. Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (7)

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates
Article By: Benzinga
Sunday, April 12, 2020 1:22 PM EDT
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact.
In this article: ABT, JNJ, ALNY, GILD, ISRG, AMRN, AXSM, SCYX, ASND, URGN, ITRM, OVID, VIR
Read
5 Best Performing IPOs Of 2017
Article By: Zacks Investment Research
Friday, December 29, 2017 6:28 PM EDT
2017 marked a bounce back for the U.S. IPO market courtesy of improving economic fundamentals and consumer sentiment. Successful IPOs poured in primarily from the biotech and technology sectors and featured the comeback of Chinese issuers.
In this article: URGN, ANAB, SGH, CLXT, ROKU, SNAP, APRN
Read
Israel-Based Biopharm, UroGen Pharma Will IPO Thursday
Article By: Don Dion
Wednesday, May 3, 2017 12:28 PM EDT
Israel-based UroGen Pharma expects to IPO on Thursday, May 4, offering 3.46 million shares at an expected price range of $12 to $14.
In this article: URGN
Read

PARTNER HEADLINES

Latest Tweets for $URGN

No tweets yet!